Swoop
Communities | Patient Insights
Swoop
Understanding the Debilitating Nature of Narcolepsy in Patients’ Own Words: A Social Listening Analysis
Background Narcolepsy is a rare, chronic hypersomnolence disorder characterized by debilitating symptoms, including excessive daytime sleepiness (EDS), cataplexy, and disrupted nighttime sleep. Symptoms most typically appear during adolescence2; however, previous reports suggest that diagnosis can be complicated by lack of symptom recognition or misdiagnoses and may be delayed by >10 years. Real-world information and experiences […]
Swoop
Eric: Pioneering Patient Engagement and Education
Eric Peacock's journey from consulting and tech to healthcare all started with a book about genetics. Eric brings his empowering and transparent leadership style to Swoop.
Swoop
DSP Diagnosis: 10 Factors Pharma Marketers Should Consider
This checklist will guide you through choosing a DSP that aligns with your objectives, respects patient privacy, and leverages cutting-edge technology.
Communities | Patient Insights
Swoop
Matching Anti-Seizure Medications’ Formulations to Patients: Why It Matters
Objective To understand the healthcare provider (HCP) and parent/caregiver dialogue regarding swallowing challenges of anti-seizure medications (ASMs) in children with epilepsy. Background Challenges swallowing oral medications among children have been shown to affect adherence to treatment. This survey is of critical importance for the practicing neurologist, as it addresses issues related to medication formulation availability […]
Communities | Patient Insights
Swoop
Patient Reported Attitudes Towards Multiple Sclerosis Treatment
Background Obstacles exist for getting patients on disease modifying treatments (DMTs) to slow progression. Understanding patient concerns can enable neurologists to help patients overcome barriers. Objective Research was undertaken to better understand awareness, usage, and attitudes towards DMTs.
Swoop
Five fast lessons from Reuters Pharma USA 2025
Here are five quick takeaways from Reuters Pharma USA 2025
Predictive Audiences | Case Studies
Swoop
A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Non-Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.
DTC Audiences | Case Studies
Swoop
Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%
A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.
DTC Audiences | Case Studies
Swoop
Activating Patients on Addressable TV Generates 1,500 New-to-Brand Starts for Type 2 Diabetes Drug
A pharmaceutical brand wanted to increase reach, doctor’s visits and drive prescription lift of its Type 2 diabetes drug nationally. Swoop built a privacy-safe segment of patients on the brand and its competitors. Targeted ads on linear addressable devices scaled across MVPDs, maximizing frequency to saturate the North American market.